Halozyme Therapeutics Inc (NASDAQ:HALO)

16.31
Delayed Data
As of 4:00pm ET
 -1.67 / -9.29%
Today’s Change
12.71
Today|||52-Week Range
22.06
-8.01%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close17.98
Today’s open17.47
Day’s range16.13 - 17.64
Volume154,694
Average volume (3 months)1,729,839
Market cap$2.4B
Data as of 4:00pm ET, 04/01/2020

Growth & Valuation

Earnings growth (last year)+10.53%
Earnings growth (this year)+225.02%
Earnings growth (next 5 years)+48.50%
Revenue growth (last year)+29.06%
P/E ratioNM
Price/Sales13.06
Price/Book26.12

Competitors

 Today’s
change
Today’s
% change
ALLOAllogene Therapeutic...-0.99-5.11%
BLUEbluebird bio Inc-3.50-7.61%
CRSPCRISPR Therapeutics ...-3.92-9.25%
DCPHDeciphera Pharmaceut...-3.82-9.28%
Data as of 4:00pm ET, 04/01/2020

Financials

Next reporting dateMay 12, 2020
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$196.0M
Annual profit (last year)-$72.2M
Net profit margin-36.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts